EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discordant and Converting Receptor Expressions in Brain Metastases from Breast Cancer: MRI-Based Non-Invasive Receptor Status Tracking

Alexander Heitkamp, Frederic Madesta iD, Sophia Amberg, Schohla Wahaj, Tanja Schröder, Matthias Bechstein iD, Lukas Meyer, Gabriel Broocks iD, Uta Hanning, Tobias Gauer, René Werner iD, Jens Fiehler und 2 weitere

Cancers · 23.05.2023 · 15 (11) · 2880

DOI: 10.3390/cancers15112880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 23.05.2023. Verfasst von Alexander Heitkamp und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Discordance and conversion of receptor expressions in metastatic lesions and primary tumors is often observed in patients with brain metastases from breast cancer. Therefore, personalized therapy requires continuous monitoring of receptor expressions and dynamic adaptation of applied targeted treatment options. Radiological in vivo techniques may allow receptor status tracking at high frequencies at low risk and cost. The present study aims to investigate the potential of receptor status prediction through machine-learning-based analysis of radiomic MR image features. The analysis is based on 412 brain metastases samples from 106 patients acquired between 09/2007 and 09/2021. Inclusion criteria were as follows: diagnosed cerebral metastases from breast cancer; histopathology reports on progesterone (PR), estrogen (ER), and human epidermal growth factor 2 (HER2) receptor status; and availability of MR imaging data. In total, 3367 quantitative features of T1 contrast-enhanced, T1 non-enhanced, and FLAIR images and corresponding patient age were evaluated utilizing random forest algorithms. Feature importance was assessed using Gini impurity measures. Predictive performance was tested using 10 permuted 5-fold cross-validation sets employing the 30 most important features of each training set. Receiver operating characteristic areas under the curves of the validation sets were 0.82 (95% confidence interval [0.78; 0.85]) for ER+, 0.73 [0.69; 0.77] for PR+, and 0.74 [0.70; 0.78] for HER2+. Observations indicate that MR image features employed in a machine learning classifier could provide high discriminatory accuracy in predicting the receptor status of brain metastases from breast cancer.

Schlagwörter

Stichwörter der Autor:innen

brain metastasesmachine learningmetastatic cancerradiomicsreceptor status

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
  • Department of Computational Neuroscience, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
  • Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
  • Center for Biomedical Artificial Intelligence (bAIome), University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.

ORCID-Profile: Frederic Madesta, Matthias Bechstein, Gabriel Broocks, René Werner

Zitieren

APA

Heitkamp, A., Madesta, F., Amberg, S., Wahaj, S., Schröder, T., Bechstein, M., Meyer, L., Broocks, G., Hanning, U., Gauer, T., Werner, R., Fiehler, J., Gellißen, S., & Kniep, H. C. (2023). Discordant and Converting Receptor Expressions in Brain Metastases from Breast Cancer: MRI-Based Non-Invasive Receptor Status Tracking. Cancers, 15(11), 2880. https://doi.org/10.3390/cancers15112880

Vancouver

Heitkamp A, Madesta F, Amberg S, Wahaj S, Schröder T, Bechstein M, et al. Discordant and Converting Receptor Expressions in Brain Metastases from Breast Cancer: MRI-Based Non-Invasive Receptor Status Tracking. Cancers. 2023;15(11):2880. doi:10.3390/cancers15112880

BibTeX
@article{Heitkamp2023,
  author = {Heitkamp, Alexander and Madesta, Frederic and Amberg, Sophia and Wahaj, Schohla and Schröder, Tanja and Bechstein, Matthias and Meyer, Lukas and Broocks, Gabriel and Hanning, Uta and Gauer, Tobias and Werner, René and Fiehler, Jens and Gellißen, Susanne and Kniep, Helge C},
  title = {Discordant and Converting Receptor Expressions in Brain Metastases from Breast Cancer: MRI-Based Non-Invasive Receptor Status Tracking},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {11},
  pages = {2880},
  doi = {10.3390/cancers15112880}
}
Kostenlos starten →